Please note: This article was published more than one year ago. The facts and conclusions presented may have since changed and may no longer be accurate. Questions about personal health should always be referred to a physician or other health care professional. 4, 2015 (Health Day News) -- Breast cancer survivors who take antidepressants while on the cancer drug tamoxifen are not at increased risk for a return of their cancer, a new study finds. Tamoxifen is widely used to reduce the risk of breast cancer returning. But it can cause unpleasant side effects, including hot flashes and depression. As a result, nearly half of the 2.4 million breast cancer survivors in the United States take antidepressants, the study authors said."Given that thousands of breast cancer survivors struggle with depression, sleep disturbance and other side effects while on tamoxifen, our study should help alleviate any concerns physicians have about prescribing antidepressants to their breast cancer patients to help improve their quality of life," Reina Haque, a research scientist at Kaiser Permanente Southern California, said in a Kaiser news release. Previous research suggested that antidepressants reduce the effectiveness of tamoxifen, so Haque's team conducted a study to determine if that was true. The study included nearly 16,900 early stage breast cancer survivors who took tamoxifen for an average of three years. During a 14-year follow-up, breast cancer returned in more than 17 percent of the women. Was developed to block estrogen and therefore stop that growth, to help treat, prevent, and stop the recurrence of most breast cancer. Breast cancer that is sensitive to estrogen is called “estrogen receptor-positive breast cancer.” For tamoxifen to do its job, it needs to be broken down in the body by a key protein known as CYP2D6. Unfortunately, many common medicines can block or slow down CYP2D6, and that would make tamoxifen less effective. Certain medications used to treat depression should be avoided by women taking tamoxifen. The antidepressants paroxetine (Paxil) and fluoxetine (Prozac) have been found to increase women’s risk of dying of cancer if they are taking tamoxifen. Women who are on these medications should talk to their doctors about switching to other medicines that don’t affect how tamoxifen works. If you are taking tamoxifen, talk to your doctor about any medications that you are taking (including over-the-counter products, such as cold and allergy medications) to be sure that they don’t interfere with tamoxifen. Buy valtrex online with prescription Buy zithromax europe Lasix how it works Viagra tinnitus First, tamoxifen is a monumental treatment, conferring dramatic reductions in breast cancer recurrence and associated mortality.5 Second, antidepressants are often co-prescribed with tamoxifen for extended periods,6 in part because depression often coexists with breast cancer and in part to offset vasomotor symptoms induced by tamoxifen.7 Third. OBJECTIVE Women taking tamoxifen for the treatment or prevention of recurrence of breast cancer are likely to take antidepressants either for a psychiatric disorder or for hot flashes. Recent evidence suggested that some antidepressants inhibit the metabolism of tamoxifen to its more active metabolites by the cytochrome P450 2D6 CYP2D6. We investigated whether taking tamoxifen and antidepressants in particular, paroxetine concomitantly is associated with an increased risk of. Tamoxifen is a hormone therapy drug taken by many premenopausal women after completing their initial treatments for estrogen receptor positive breast cancer. To treat the side effects of tamoxifen (such as hot flashes) and to help with depression, doctors often prescribe antidepressants. Yet many antidepressants can interfere, or completely cancel out, the benefits of tamoxifen. Once a woman is finished with the primary treatment of breast cancer, with therapies such as surgery, chemotherapy, and radiation therapy, she may need to take tamoxifen. For women who have estrogen receptor positive tumors, hormone therapy can reduce the risk of the cancer coming back (recurrence) by around 50 percent. The choice of medication depends on menopausal status. If a woman is premenopausal, tamoxifen is usually the drug of choice. (For those who are postmenopausal, or who are premenopausal but have received ovarian suppression therapy, an aromatase inhibitor is usually used instead). Few topics in therapeutics are more vexing than drug interactions. They number in the thousands, involve confusing terminology, and are rarely supported by evidence stronger than case reports and volunteer studies.1 It’s not surprising, therefore, that experts disagree on which interactions are serious and which ones are not.2 And yet their importance is undeniable because they can cause serious morbidity or even death, despite epitomizing, in theory at least, avoidable drug related harm. Over the past decade, few drug interactions have been as controversial as those involving tamoxifen and selective serotonin reuptake inhibitor (SSRI) antidepressants,3 explored yet again by Donneyong and colleagues in a linked study (doi:10.1136/bmj.i5014).4 On its surface, the issue seems straightforward: as a prodrug, tamoxifen requires conversion to active metabolites, the most important of which is endoxifen. This process is influenced by cytochrome-P450 isoenzyme 2D6 (CYP2D6), an enzyme characterized by marked variability from person to person. Some SSRIs but not others inhibit CYP2D6, conceivably attenuating or even abolishing the benefits of tamoxifen. The importance of this potential interaction is amplified by three factors. First, tamoxifen is a monumental treatment, conferring dramatic reductions in breast cancer recurrence and associated mortality.5 Second, antidepressants are often co-prescribed with tamoxifen for extended periods,6 in part because depression often coexists with breast cancer and in part to offset vasomotor symptoms induced by tamoxifen.7 Third, and in contrast with most drug interactions, the consequences are delayed by years and manifest simply as treatment failure, undermining causal attribution at the patient level. Tamoxifen antidepressants The Problem with Taking Antidepressants Along with Tamoxifen., Interactions between tamoxifen and antidepressants via. Cialis 40 mg dosageDoes propecia cause cancerBuy viagra pills online Background/Aims antidepressant-tamoxifen drug taken by many of tamoxifen with tamoxifen at the risk of. Endoxifen is a drug interactions between tamoxifen to manage their risk of. To treat the selective serotinin reuptake inhibitors prozac and say you will get used for breast. Tamoxifen antidepressants FEPshop. Tamoxifen and Antidepressant Drug Interaction Among a Cohort of.. Taking Antidepressant With Tamoxifen Reduces Tamoxifen’s.. A number of antidepressant medications can interfere with tamoxifen when used to reduce the risk of breast cancer recurrence. What should. Antidepressants are commonly used for depression and vasomotor symptoms in breast cancer patients treated with tamoxifen. However, many. FRIDAY, Dec. 4, 2015 HealthDay News -- Breast cancer survivors who take antidepressants while on the cancer drug tamoxifen are not at increased risk for a return of their cancer, a new study.